Agency
Virginia Department of Health
 
Board
State Board of Health
 
chapter
Regulations for the Immunization of School Children [12 VAC 5 ‑ 110]
Previous Comment     Next Comment     Back to List of Comments
10/14/21  9:43 am
Commenter: Anonymous

Protease TMPRSS2 Inhibitors like IVERMECTIN deny S1/S2 separation - S2 is Entry Mechanism
 

Protease TMPRSS2 Inhibitors like IVERMECTIN deny S1/S2 separation - S2 is Entry Mechanism

If S1 binds to ACE2 - TMPRSS2 cleaves S1 from the rest of the virus - S1 remains in ACE2 - then free floats causing further inflammation and Syncytia...

After TMPRSS2 cleaves S1 - S2 is revealed, "unfolds", and penetrates the cell membrane allowing entry the rest of the virus.

If S2 is never "revealed" the rest of the virus cannot enter the cell.

Why mandate medical experimentation on CHILDREN when medical pharmacological science may reduce the 0.0002% risk with many examples of "COVID FREE" zones like Uttar Pradesh, India with 5% vaxx rate.

Why mandate inclusion in experimental mRNA therapy for children when it would be more medically and fiscally responsible to arm every nurses station with basic WHO essential medicines like Ivermectin?

CommentID: 109823